BIOMAT Database Logo BIOMAT Database Logo

Interferon-gamma (r-IFN-gamma) induced activation of alveolar macrophages (AM) from anergic patients with chronic obstructive pulmonary disease (COPD). 1992

T Todisco, and A Vecchiarelli, and M Dottorini, and A Eslami, and A Bertotto, and M Massucci, and S Crupi, and E Cenci, and C Arcangeli, and P G Fabietti
Pulmonary Division, University Hospital of Perugia, Italy.

Forty-six anergic patients (37 males and 9 females, age range 55-79 yr) were selected from ninety-one patients suffering from COPD due to frequent exacerbations and impaired delayed cutaneous reactivity (43.9%). The phenotype of circulating lymphocytes, their proliferative response to a panel of polyclonal T-cell activators and the candidacidal activity (CA) of circulating PMNs (polymorphonuclear cells) were measured. In 13 patients presenting a defective CA of circulating PMNs, the in vitro response of alveolar macrophage CA to r-IFN-gamma was also determined. We found: 1) a significant reduction in the CL response to PHA in COPD patients vs controls; 2) a low PMN-CA in 23 (57%) COPD patients; 3) a non-significant difference in phenotype analysis in patients and controls; 4) lower CA of AMs in COPD patients than in controls; 5) restoration in vitro of CA by r-IFN-gamma in the group of anergic COPD patients presenting depressed CA. We conclude that a defective cell-mediated immunity could be the basis of the enhanced susceptibility to infectious exacerbations in many COPD patients and that, in vitro, it could be reversed by r-IFN-gamma treatment.

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008173 Lung Diseases, Obstructive Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent. Obstructive Lung Diseases,Obstructive Pulmonary Diseases,Lung Disease, Obstructive,Obstructive Lung Disease,Obstructive Pulmonary Disease,Pulmonary Disease, Obstructive,Pulmonary Diseases, Obstructive
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008262 Macrophage Activation The process of altering the morphology and functional activity of macrophages so that they become avidly phagocytic. It is initiated by lymphokines, such as the macrophage activation factor (MAF) and the macrophage migration-inhibitory factor (MMIF), immune complexes, C3b, and various peptides, polysaccharides, and immunologic adjuvants. Activation, Macrophage,Activations, Macrophage,Macrophage Activations
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA

Related Publications

T Todisco, and A Vecchiarelli, and M Dottorini, and A Eslami, and A Bertotto, and M Massucci, and S Crupi, and E Cenci, and C Arcangeli, and P G Fabietti
Alveolar macrophages in chronic obstructive pulmonary disease (COPD).
January 2004, Cellular and molecular biology (Noisy-le-Grand, France),
T Todisco, and A Vecchiarelli, and M Dottorini, and A Eslami, and A Bertotto, and M Massucci, and S Crupi, and E Cenci, and C Arcangeli, and P G Fabietti
Evidence of a defective thiol status of alveolar macrophages from COPD patients and smokers. Chronic obstructive pulmonary disease.
December 2000, Free radical biology & medicine,
T Todisco, and A Vecchiarelli, and M Dottorini, and A Eslami, and A Bertotto, and M Massucci, and S Crupi, and E Cenci, and C Arcangeli, and P G Fabietti
Human alveolar macrophages of anergic patients with lung cancer lack the responsiveness to recombinant interferon gamma.
November 1991, Chest,
T Todisco, and A Vecchiarelli, and M Dottorini, and A Eslami, and A Bertotto, and M Massucci, and S Crupi, and E Cenci, and C Arcangeli, and P G Fabietti
[Bioinformatical analysis of differentially expressed genes in alveolar macrophages of chronic obstructive pulmonary disease(COPD)].
November 2020, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology,
T Todisco, and A Vecchiarelli, and M Dottorini, and A Eslami, and A Bertotto, and M Massucci, and S Crupi, and E Cenci, and C Arcangeli, and P G Fabietti
Role of alveolar macrophages in chronic obstructive pulmonary disease.
January 2014, Frontiers in immunology,
T Todisco, and A Vecchiarelli, and M Dottorini, and A Eslami, and A Bertotto, and M Massucci, and S Crupi, and E Cenci, and C Arcangeli, and P G Fabietti
[Clinical usefulness of serum IFN-gamma level in patients with chronic obstructive pulmonary disease].
September 1999, Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao,
T Todisco, and A Vecchiarelli, and M Dottorini, and A Eslami, and A Bertotto, and M Massucci, and S Crupi, and E Cenci, and C Arcangeli, and P G Fabietti
Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease.
January 2003, American journal of respiratory and critical care medicine,
T Todisco, and A Vecchiarelli, and M Dottorini, and A Eslami, and A Bertotto, and M Massucci, and S Crupi, and E Cenci, and C Arcangeli, and P G Fabietti
[Chronic obstructive pulmonary disease (COPD)].
June 2012, Deutsche medizinische Wochenschrift (1946),
T Todisco, and A Vecchiarelli, and M Dottorini, and A Eslami, and A Bertotto, and M Massucci, and S Crupi, and E Cenci, and C Arcangeli, and P G Fabietti
[Chronic obstructive pulmonary disease (COPD)].
June 2003, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society,
T Todisco, and A Vecchiarelli, and M Dottorini, and A Eslami, and A Bertotto, and M Massucci, and S Crupi, and E Cenci, and C Arcangeli, and P G Fabietti
[Chronic obstructive pulmonary disease (COPD)].
July 2003, Anales de medicina interna (Madrid, Spain : 1984),
Copied contents to your clipboard!